University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Focal Airway Disease in Asthma Using Image Guided Bronchoscopy

Withdrawn

Conditions: Asthma
Mucus; Plug, Tracheobronchial

Interventions: Radiation: Multidetector Computed Tomography (MDCT) Scan
Procedure: Virtual Navigation Bronchoscopy (VNB)

First Posted Date: 2020-08-17

Last Posted Date: 2023-02-21

Lead Sponsor: University of California, San Francisco

Registration Number: NCT04514913

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins

Recruiting

Conditions: Therapeutic Proteins
Asthma

First Posted Date: 2020-08-17

Last Posted Date: 2023-02-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 120

Registration Number: NCT04514926

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Foster Care Mental Health Family Navigator

Not Applicable

Recruiting

Conditions: Mental Health

Interventions: Behavioral: Family-based mental health navigation
Behavioral: Standard of care engagement practices

First Posted Date: 2020-08-10

Last Posted Date: 2023-05-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 125

Registration Number: NCT04506437

Locations: 🇺🇸
UCSF Zuckerberg San Francisco General Hospital, San Francisco, California, United States

CT Guided CI Programming

Not Applicable

Active, not recruiting

Conditions: Amusia
Cochlear Implants
Hearing Loss

Interventions: Other: CT Guided Cochlear Implant Programming

First Posted Date: 2020-08-10

Last Posted Date: 2023-06-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 19

Registration Number: NCT04506424

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Family Telehealth Project for Foster Care Youth

Not Applicable

Recruiting

Conditions: Parent-Child Relations
Communication

Interventions: Behavioral: Family-based Telehealth Intervention

First Posted Date: 2020-07-28

Last Posted Date: 2024-05-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 300

Registration Number: NCT04488523

Locations: 🇺🇸
UCSF Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

Phase 4

Completed

Conditions: Drug-Drug Interaction
HIV Infection

Interventions: Drug: Dihydroartemisinin-piperaquine

First Posted Date: 2020-07-27

Last Posted Date: 2022-05-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 190

Registration Number: NCT04487145

Locations: 🇺🇬
Masafu General Hospital (MGH) at Busia District, Eastern Uganda, Masafu, Busia, Uganda
🇺🇬
Baylor-Uganda Center of Excellence on Mulago Hospital Complex and Masafu General Hospital, Kampala, Uganda

DISulfiram for COvid-19 (DISCO) Trial

Phase 2

Terminated

Conditions: Covid19

Interventions: Drug: Placebo
Drug: Disulfiram

First Posted Date: 2020-07-24

Last Posted Date: 2023-09-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT04485130

Locations: 🇺🇸
University of California San Francisco, Fresno, Fresno, California, United States
🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Phase 1

Recruiting

Conditions: High Grade Glioma
Low-grade Glioma
Recurrent World Health Organization (WHO) Grade II Glioma

Interventions: Drug: Everolimus
Drug: Trametinib

First Posted Date: 2020-07-24

Last Posted Date: 2024-04-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 50

Registration Number: NCT04485559

Locations: 🇺🇸
Children's Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

and more 14 locations

Induced Pluripotent Stem Cells for Disease Research

Completed

Conditions: Hirschsprung Disease

First Posted Date: 2020-07-20

Last Posted Date: 2022-10-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1

Registration Number: NCT04476225

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

The Effect of Chronic Pain on Delay Discounting in Methadone Patients

Phase 1

Terminated

Conditions: Chronic Pain Syndrome
Opioid-use Disorder

Interventions: Drug: Naloxone Hydrochloride
Drug: Placebo

First Posted Date: 2020-07-16

Last Posted Date: 2022-10-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 29

Registration Number: NCT04473950

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy